Physician profile
James A Smith
NPI 1619973906
$7,123.14
in general payments reported to CMS, 2019-2025
19 companies · $81.33 in 2025
The $81.33 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,738 · 2020: $528 · 2021: $341 · 2022: $645 · 2023: $315 · 2024: $2,475 · 2025: $81.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,469 · Food and Beverage: $1,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,468.81 |
| Food and Beverage | $1,401.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,755.47 | 2019-2025 | Jot Dx |
| Penumbra, INC. | $2,148.07 | 2023-2024 | Ruby Coil, Indigo System |
| Philips North America LLC | $954.29 | 2019-2022 | |
| Abiomed | $312.08 | 2019 | |
| Shockwave Medical, INC | $132.16 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals Lp | $124.79 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $120.39 | 2020 | |
| Jazz Pharmaceuticals INC. | $98.82 | 2020 | |
| Boston Scientific Corporation | $96.40 | 2022-2023 | Jetstream Sc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $74.62 | 2019-2023 | Xarelto |
| Lemaitre Vascular, INC. | $54.34 | 2022 | |
| Medtronic, INC. | $52.67 | 2021 | |
| Bardy Diagnostics, INC. | $31.72 | 2020-2021 | |
| Amarin Pharma, INC. | $19.02 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.70 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.94 | 2021 | |
| Amgen INC. | $12.61 | 2020 | |
| Pfizer INC. | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.